What Is Subglottic Stenosis? Causes, Symptoms, & Treatment

Subglottic stenosis is a narrowing of the airway just below the vocal cords, at the level of the ring-shaped cricoid cartilage that forms the base of the larynx. The narrowing restricts airflow and can cause progressive breathing difficulty, noisy breathing, and exercise intolerance. It can be present from birth or develop later in life, most commonly as a complication of prolonged intubation, though some cases arise without any clear trigger. Because its symptoms overlap with asthma and other common conditions, subglottic stenosis is frequently misdiagnosed, sometimes for years.

Where Exactly the Narrowing Happens

The subglottis is the short segment of airway that sits between the vocal cords above and the first tracheal ring below. It is encircled by the cricoid cartilage, the only complete cartilage ring in the airway. That completeness matters: unlike the C-shaped tracheal rings, the cricoid cannot flex outward to accommodate swelling or scar tissue. Any thickening of the tissue lining this region directly reduces the airway’s diameter.¹ In adults, the subglottis is already one of the narrowest points in the entire airway, so even modest scarring can produce noticeable symptoms. In infants and small children, the passage is proportionally even tighter, which is why even mild congenital narrowing can cause stridor (a high-pitched breathing sound) in the first months of life.

Acquired Causes

The most common reason adults develop subglottic stenosis is prolonged endotracheal intubation, the kind that happens during extended stays in an intensive care unit. When a breathing tube sits in the airway for days or weeks, it presses against the delicate mucosal lining of the subglottis. That pressure causes ulceration, most often along the back and sides of the cricoid ring.² The ulcers heal with fibrous scar tissue, and if the scarring is extensive enough, it narrows the airway permanently.

At a cellular level, the tube triggers a chain of events: mucosal inflammation, reduced blood flow to the tissue (local hypoxia), and mechanical stress. Together, these promote excessive collagen and tissue deposition, the same kind of runaway wound-healing process seen in keloid scars on the skin.³ Not everyone who is intubated develops stenosis, and researchers still do not fully understand why some patients scar heavily while others heal cleanly. Factors like tube size relative to the airway, duration of intubation, infection, and gastroesophageal reflux all seem to play a role.

Idiopathic Subglottic Stenosis and the Estrogen Question

When no clear cause can be identified, the condition is called idiopathic subglottic stenosis, or iSGS. This form has a striking demographic pattern: it affects almost exclusively women, typically during their reproductive or perimenopausal years.⁴ That lopsided sex distribution has led researchers to investigate whether estrogen and progesterone drive the abnormal scarring process. The hypothesis is that female hormones stimulate collagen deposition in upper-airway tissue, turning what might otherwise be a minor injury into progressive fibrosis.⁵

Studies have identified estrogen and progesterone receptors in the scar tissue of iSGS patients, and estrogen exposure has been explored as a potential pathophysiological factor.⁶ The evidence is still evolving, and a definitive causal link has not been established. But the pattern is real enough that clinicians treating iSGS are aware of it, and it is one of the more active areas of research in this field. Gastroesophageal reflux is another frequently observed association: in one study of patients with iSGS, about half had confirmed abnormal reflux on formal testing, and the vast majority of those had predominantly upright acid reflux.⁷ Whether reflux causes, worsens, or merely coexists with iSGS remains an open question, but many treating physicians address reflux aggressively as part of the management plan.

Autoimmune and Inflammatory Causes

Several autoimmune conditions can target the subglottis. The most well-known is granulomatosis with polyangiitis (GPA, formerly called Wegener’s granulomatosis), a disease characterized by inflammation of blood vessels and formation of granulomas throughout the body. Subglottic stenosis occurs in roughly 16 to 23 percent of GPA cases and can appear either as an early presenting symptom or as a complication that develops later in the course of the disease.⁸ GPA-related stenosis is considered potentially life-threatening and can recur even when the patient is receiving systemic immunosuppressive therapy.⁹

Other conditions that can cause or contribute to subglottic narrowing include sarcoidosis, relapsing polychondritis, and certain forms of inflammatory bowel disease-associated airway inflammation. These are all far less common than post-intubation stenosis, but they matter because treatment needs to address the underlying systemic disease, not just the airway scar.

Congenital Subglottic Stenosis

Some children are born with a subglottis that is already too narrow. The most frequent anatomical explanation is an abnormally shaped cricoid cartilage, often described as elliptical rather than the usual round shape. This variant has been identified both in postmortem specimens and in living patients through endoscopic evaluation.¹⁰ In rarer cases, a cartilaginous outgrowth from the cricoid can obstruct the airway so severely that virtually no lumen is visible, grading as the most severe form on standard classification scales.¹¹

Congenital subglottic stenosis is associated with certain genetic conditions. Children with Down syndrome have a higher-than-expected rate of airway problems, with symptomatic subglottic stenosis documented in a meaningful subset of those evaluated for airway concerns.¹² It has also been reported in Pallister-Killian syndrome, a rare chromosomal disorder.¹³ Mild congenital narrowing sometimes resolves as the child grows and the airway expands, but moderate to severe cases typically need intervention.

Symptoms and the Misdiagnosis Problem

The symptoms of subglottic stenosis tend to creep in gradually, which is part of why it gets missed. The most common complaints are shortness of breath with exertion, noisy breathing (especially on inhaling), a persistent cough, and a change in voice quality. In more severe cases, breathing difficulty occurs even at rest. These symptoms mimic asthma so closely that patients are routinely treated with inhalers and steroids for months or years before anyone looks below the vocal cords. Case reports have documented patients with iSGS who carried an asthma diagnosis for extended periods before the true cause was identified through endoscopic evaluation.¹⁴

A key clinical clue is that the breathing difficulty in subglottic stenosis is often more pronounced during inhalation (inspiratory stridor), whereas typical asthma predominantly affects exhalation. If you have been diagnosed with asthma but your symptoms do not improve with standard asthma treatment, and especially if you have a history of intubation or an autoimmune condition, the possibility of a fixed upper-airway narrowing is worth raising with your doctor.

How Stenosis Is Graded and Diagnosed

The definitive diagnosis comes from direct visualization with a scope. Laryngoscopy or bronchoscopy lets a clinician see the narrowed segment, assess how much of the airway circumference is involved, and assign a severity grade. The most widely used grading system is the Cotton-Myer classification, which sorts stenosis into four grades based on the percentage of the airway lumen that is obstructed: grade I is up to 50 percent obstruction, grade II is 51 to 70 percent, grade III is 71 to 99 percent, and grade IV is complete obstruction with no detectable opening.¹⁵

Imaging studies like CT scans can show the narrowing and help with surgical planning, and correlation between radiographic measurements and endoscopic findings is an active area of study. But the endoscope remains the gold standard because it provides a real-time, dynamic view of the airway and allows the clinician to assess the firmness and thickness of the scar tissue.

Endoscopic Treatment

For many patients, especially those with less severe stenosis or those seeking to avoid open surgery, endoscopic procedures are the first-line approach. These are performed through the mouth under general anesthesia, without external incisions. The typical combination involves using a laser or a cold knife to cut through the scar tissue, followed by balloon dilation to widen the airway. Topical agents are often applied during the same procedure to discourage the scar from reforming. In one large series of 219 endoscopic operations, the combination of laser and balloon dilation was used in about half the cases, with balloon dilation alone accounting for most of the remainder.¹⁶

Adjunctive therapies during endoscopic procedures include mitomycin C (a drug that inhibits fibroblast activity and scar formation) and steroid injections directly into the scar tissue. In that same series, mitomycin was applied in about two-thirds of cases and steroid injection in about 40 percent. These agents are used to try to break the cycle of scar, dilation, re-scar that is the central frustration of treating this condition.¹⁷

Open Surgical Options

When endoscopic treatment fails to provide lasting relief, or when the stenosis is too severe or too long for a scope-based approach, open surgery becomes necessary. The two main procedures are laryngotracheal reconstruction (LTR) and partial cricotracheal resection (PCTR). In LTR, a cartilage graft (often harvested from a rib) is used to expand the narrowed segment. In PCTR, the scarred portion of the airway is removed entirely and the healthy ends are reconnected.

A systematic review and meta-analysis comparing these two approaches in children with moderate-grade stenosis found successful decannulation (removal of a tracheostomy tube) in about 84 percent of LTR cases and about 97 percent of PCTR cases, though the difference was not statistically significant. PCTR showed slightly better outcomes for voice and swallowing, while LTR carried a higher risk of restenosis and the need for additional surgeries.¹⁸ The choice between these procedures depends on the length and location of the stenosis, the patient’s age and anatomy, and the surgeon’s experience.

Airway Stenting

For patients with refractory stenosis who are not candidates for resection, or as a bridge to more definitive surgery, airway stents can hold the passage open. Several types exist. The Montgomery T-tube is a silicone stent placed through a tracheostomy site, with one arm projecting externally. In a study of 32 patients treated with T-tubes for benign subglottic stenosis, all patients developed secretion retention to some degree, and about 28 percent developed granulation tissue growth around the stent. Most of these complications were manageable with regular bronchoscopic cleaning, though a small number required stent removal due to severe secretion buildup.¹⁹

Another option, the LT-Mold, is a softer silicone prosthesis designed for long-term stenting of complex laryngotracheal stenosis. In a series of 65 patients, 83 percent were successfully decannulated after a mean stenting duration of three months, with a follow-up period averaging close to two years.²⁰ Short bronchial Dumon stents have also been tried for refractory post-intubation cases, with about 79 percent of patients tolerating the stent well at six months, though granulation tissue formation and stent migration remain common issues.²¹ Stenting is not a permanent fix; it buys time and maintains airway patency while the underlying process is managed.

Recurrence Is the Central Challenge

Perhaps the most important thing to understand about subglottic stenosis is that it tends to come back. A systematic review and meta-analysis of endoscopic interventions in adults found an overall recurrence rate of about 60 percent, and for balloon dilation specifically, the rate was closer to 68 percent.²² This does not mean endoscopic treatment is ineffective; many patients do well for years between procedures and prefer periodic dilations to the risks of open surgery. But it does mean the disease is often managed rather than cured.

In patients with iSGS treated with endoscopic laser wedge excision, the median time to recurrence after a first procedure was about 4.6 years. For those who had already undergone prior operations, that interval shrank to about 2.9 years. A notable finding from that study was that greater compliance with medical therapy (typically reflux management and topical anti-inflammatory treatments) was associated with a longer time before recurrence.²³ This reinforces the idea that ongoing medical management, not just the procedure itself, matters for keeping the airway open.

Voice and Quality of Life

Subglottic stenosis and its treatment can affect the voice, which makes sense given how close the stenosis sits to the vocal cords. Research has found a direct connection between improvements in airway caliber after treatment and improvements in voice-related quality of life. Specifically, for every 10 percent improvement in airway opening, patients experienced a small but meaningful gain in voice quality-of-life scores, and this held true regardless of the type of treatment used.²⁴

Serial steroid injections into the scar tissue, a minimally invasive approach used in some iSGS patients, appear to provide modest voice benefits. In a study tracking outcomes after steroid-only treatments, about half of encounters showed improvement in voice-related quality of life, while about a quarter showed worsening. The average improvement across all patients was small but statistically significant.²⁵

For children who undergo open airway reconstruction, voice outcomes range from normal to moderately impaired. What is interesting is that the degree of voice change measured on objective tests does not always match how much it bothers the child in daily life. Some children with measurably abnormal voices report good quality of life, while others with milder changes are more affected.²⁶ This disconnect is worth keeping in mind for parents weighing surgical options.

The Anesthesia Challenge in Severe Cases

One practical reality that patients with severe stenosis face is the difficulty of securing the airway for any surgical procedure, even the one meant to fix the stenosis itself. The standard approach to general anesthesia involves placing a breathing tube through the narrowed area, which may be physically impossible when the stenosis is tight. Anesthesiologists working with these patients often need specialized techniques such as awake fiberoptic intubation, where the patient remains conscious while a flexible scope guides a smaller-than-usual tube through the obstruction.²⁷ In some cases, a tracheostomy or other front-of-neck airway access may need to be established first.²⁸ This is not just a technical footnote for medical teams. For patients, it means that any procedure requiring general anesthesia, even one unrelated to the airway, needs careful pre-operative planning and communication with the anesthesia team about the stenosis.

What Molecular Research Is Pointing Toward

The reason subglottic stenosis keeps recurring after treatment is fundamentally about biology, not about surgical technique. The scar tissue that forms in the subglottis is not ordinary wound healing gone slightly overboard; it appears to involve a distinct set of molecular drivers. Recent work has identified roles for specific growth factors, cytokines, altered fibroblast behavior, and possible genetic susceptibility that interact in complex ways to drive fibrotic wound healing after an initial insult.²⁹ Understanding these pathways matters because the treatments currently available are essentially mechanical: cut or stretch the scar, apply an anti-scarring agent, and hope for the best. A clearer molecular picture could eventually lead to targeted therapies that prevent the scar from forming in the first place, rather than repeatedly removing it after the fact. That shift from reactive to preventive treatment is what the field is working toward, but no such drug therapy has yet reached routine clinical use for this condition.